Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Q-Line Biotech IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Financial Information of Q-Line Biotech Limited IPO
The Revenues from operations for the Period ended on Dec 31 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹
23,650.25 Lakh, ₹
32,258.42 Lakh, ₹
20,644.81 Lakh, and ₹
18,481.15 Lakh, The EBITDA for the Period ended on Dec 31 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were ₹
6,422.98 Lakh, ₹
7,132.12 Lakh, ₹
3,762.50 Lakh, and ₹
3,297.72 Lakh, The Profit after Tax for the Period ended on Dec 31 2025, and Fiscals ended on Mar 31, 2025, 2024 and 2023 were were ₹
3,869.39 Lakh, ₹
2,813.09 Lakh, ₹
3,444.47 Lakh, and ₹
3,209.71 Lakh, respectively. This indicates a steady growth in financial performance.
Q-Line Biotech Limited Financial Information (Restated Consolidated)
Amount in (₹ in Lakhs)
| Period Ended | Dec 31, 2025 | Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 |
|---|---|---|---|---|
| Reserve of Surplus | 21,288.92 | 18,837.03 | 16,023.94 | 12,579.02 |
| Total Assets | 56,133.99 | 45,548.59 | 33,924.60 | 25,157.96 |
| Total Borrowings | 24,385.47 | 16,494.98 | 9,691.00 | 7,364.84 |
| Fixed Assets | 5,377.65 | 5,347.24 | 5,487.04 | 2,272.31 |
| Cash | 5,582.48 | 4,702.60 | 2,995.59 | 9,001.92 |
| Cash flow from operating activities | -3,311.44 | -132.20 | -2,417.94 | 2,496.86 |
| Cash flows from investing activities | -2,706.69 | -5,909.25 | -4,468.78 | -2,631.38 |
| Cash flow from financing activities | 6,609.08 | 5,333.98 | 1,698.62 | 2,640.34 |
| Net Borrowing | 18,802.99 | 11,792.38 | 6,695.41 | -1,637.08 |
| Revenue | 23,650.25 | 32,258.42 | 20,644.81 | 18,481.15 |
| EBITDA | 6,422.98 | 7,132.12 | 3,762.50 | 3,297.72 |
| PAT | 3,869.39 | 2,813.09 | 3,444.47 | 3,209.71 |
| PAT Margin | 16.36% | 8.72% | 16.68% | 17.37% |
| EPS | 23.57 | 28.63 | 21.87 | 20.38 |
Note 1:- RoE, ROCE & RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit/Loss for the Year) on 31st Mar, 2025 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2025 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price Post Issue Data, given in FINANCIAL EXPRESS.
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
